CM II PreMix Team QUIZ

CM II PreMix Team QUIZ

Professional Development

15 Qs

quiz-placeholder

Similar activities

Revisão N1

Revisão N1

Professional Development

10 Qs

ild leap 2.0- team 4

ild leap 2.0- team 4

Professional Development

10 Qs

Insulin Launch Quiz

Insulin Launch Quiz

Professional Development

18 Qs

Standards of Care: Infection Prevention

Standards of Care: Infection Prevention

Professional Development

16 Qs

novoCare Quiz

novoCare Quiz

Professional Development

16 Qs

Latihan Soal UKAI 2021

Latihan Soal UKAI 2021

11th Grade - Professional Development

10 Qs

Diabetes Mellitus

Diabetes Mellitus

Professional Development

10 Qs

Xultophy® Quiz

Xultophy® Quiz

Professional Development

15 Qs

CM II PreMix Team QUIZ

CM II PreMix Team QUIZ

Assessment

Quiz

Professional Development

Professional Development

Medium

Created by

Salman Anzar

Used 10+ times

FREE Resource

15 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

The 26 weeks EasyMix study suggested that initiation of treatment with BIAsp 30 or IGlar OD improves glycemic control among patients with T2DM in China and Japan.

True

False

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

____ Patients randomized in EasyMix Study in 1:1 in BiAsp 30 OD Vs IGlar 100 OD?

521 Insulin Experienced Patients

521 Insulin Naive Patients

553 Insulin Experienced Patients

554 Insulin Naive Patients

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Participants in the EasyMix Study who achieved HbA1c <7.0% with BiAsp 30 were ___?

33 %

30.0 %

29.1 %

30.7%

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

In both the studies BiAsp 30 & Glargine Used in OD then "How EasyMix differentiates from OnceMix Study"?

OnceMix is RCT while EasyMix is a Real World Study

Only 3 Countries Population Included in EasyMix

Self-Monitored Titration in EasyMix Study

To check the Reduction in Minor hypos

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

In Strojek et al. Subjects had an increased risk of __________ with BIAsp 30 Versus Glargine U100?

Overall Severe Hypoglycaemia

Minor and major hypoglycaemias

minor nocturnal hypoglycaemia

None of these

6.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

OnceMix is 26-week, open-labelled, randomized, parallel-group, multinational, treat-to-target trial, 480 insulin naive subjects.

True

False

7.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

When a GLP-1 receptor agonist is added to NovoMix® 30, a _____ dose reduction is recommended for type 1 & type 2 diabetes patients.

15 to 20%

20%

Both A & B

None of these

Create a free account and access millions of resources

Create resources
Host any resource
Get auto-graded reports
or continue with
Microsoft
Apple
Others
By signing up, you agree to our Terms of Service & Privacy Policy
Already have an account?